Biblio

Found 1174 results

2009

Ishak WWilliam, Davis M, Jeffrey J, Balayan K, Pechnick RN, Bagot K, Rapaport MHyman. 2009. The role of dopaminergic agents in improving quality of life in major depressive disorder.. Curr Psychiatry Rep. 11(6):503-8.

Siegel JM. 2009. Sleep viewed as a state of adaptive inactivity.. Nature Reviews Neuroscience. 10(10):747-53.

Cole SW. 2009. Social regulation of human gene expression.. Curr Dir Psychol Sci. 18(3):132-137.

Dickerson SS, Gable SL, Irwin MR, Aziz N, Kemeny ME. 2009. Social-evaluative threat and proinflammatory cytokine regulation: an experimental laboratory investigation.. Psychol Sci. 20(10):1237-44.

Sloan EK, Ciocca DR, Pouliot N, Natoli A, Restall C, Henderson MA, Fanelli MA, Cuello-Carrión FD, Gago FE, Anderson RL. 2009. Stromal cell expression of caveolin-1 predicts outcome in breast cancer.. Am J Pathol. 174(6):2035-43.

Lee J-W, Shahzad MMK, Lin YG, Armaiz-Pena G, Mangala LS, Han H-D, Kim H-S, Nam EJi, Jennings NB, Halder J et al.. 2009. Surgical stress promotes tumor growth in ovarian carcinoma.. Clin Cancer Res. 15(8):2695-702.

Sanz JH, Karlsgodt KH, Bearden CE, van Erp TGM, Nandy RR, Ventura J, Nuechterlein K, Cannon TD. 2009. Symptomatic and functional correlates of regional brain physiology during working memory processing in patients with recent onset schizophrenia. Psychiatry Research: Neuroimaging. 173:177–182.

Ventura J, Hellemann GS, Thames AD, Koellner V, Nuechterlein KH. 2009. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: A meta-analysis. Schizophrenia Research. 113:189–199.

O'Connor M-F, Bower JE, Cho HJin, J Creswell D, Dimitrov S, Hamby ME, Hoyt MA, Martin JL, Robles TF, Sloan EK et al.. 2009. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.. Brain Behav Immun. 23(7):887-97.

Irwin MR, Olmstead R, Valladares EM, Breen ECrabb, Ehlers CL. 2009. Tumor necrosis factor antagonism normalizes rapid eye movement sleep in alcohol dependence.. Biol Psychiatry. 66(2):191-5.

Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF et al.. 2009. Validity of the Prodromal Risk Syndrome for First Psychosis: Findings From the North American Prodrome Longitudinal Study. Schizophrenia Bulletin. 35:894–908.

Way BM, Taylor SE, Eisenberger NI. 2009. Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection.. Proc Natl Acad Sci U S A. 106(35):15079-84.

Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, Irwin MR, Clair J, Smith JG, Stanley H et al.. 2009. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.. J Infect Dis. 200(7):1068-77.

Cannon T.D. 2009. What Is the Role of Theories in the Study of Schizophrenia? Schizophrenia Bulletin. 35:563–567.

O'Connor M-F, Irwin MR, Wellisch DK. 2009. When grief heats up: pro-inflammatory cytokines predict regional brain activation.. Neuroimage. 47(3):891-6.

Karlsgodt KH, Niendam TA, Bearden CE, Cannon TD. 2009. White Matter Integrity and Prediction of Social and Role Functioning in Subjects at Ultra-High Risk for Psychosis. Biological Psychiatry. 66:562–569.

2008

Klumpp K, Kalayanov G, Ma H, Le Pogam S, Leveque V, Jiang W-R, Inocencio N, De Witte A, Rajyaguru S, Tai E et al.. 2008. 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.. J Biol Chem. 283(4):2167-75.

Tyler LS, Cole SW, J May R, Millares M, Valentino MA, Vermeulen LC, Wilson AL. 2008. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system.. Am J Health Syst Pharm. 65(13):1272-83.

Irwin MR, Davis M, Zautra A. 2008. Behavioral Comorbidities in Rheumatoid Arthritis: A Psychoneuroimmunological Perspective.. Psychiatr Times. 25(9):1.

Bower JE. 2008. Behavioral symptoms in patients with breast cancer and survivors.. J Clin Oncol. 26(5):768-77.

Low CA, Bower JE, Kwan L, Seldon J. 2008. Benefit finding in response to BRCA1/2 testing.. Ann Behav Med. 35(1):61-9.

Lutgendorf SK, Lamkin DM, Jennings NB, Arevalo JMG, Penedo F, DeGeest K, Langley RR, Lucci JA, Cole SW, Lubaroff DM et al.. 2008. Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.. Clin Cancer Res. 14(21):6839-46.

Lyamin OI, Manger PR, Ridgway SH, Mukhametov LM, Siegel JM. 2008. Cetacean sleep: an unusual form of mammalian sleep.. Neurosci Biobehav Rev. 32(8):1451-84.

Davis MC, Zautra AJ, Younger J, Motivala SJ, Attrep J, Irwin MR. 2008. Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue.. Brain Behav Immun. 22(1):24-32.

Ventura J, Cienfuegos A, Boxer O, Bilder R. 2008. Clinical global impression of cognition in schizophrenia ({CGI}-{CogS}): Reliability and validity of a co-primary measure of cognition. Schizophrenia Research. 106:59–69.

Pages